Cell Culture Market Growth, Regional Analysis, Trends and Forecast 2023 to 2033

The global Cell Culture Market sales is expected to be worth US$ 25.4 billion in 2022 and US$ 29 billion in 2023. Because of rising demand for biopharmaceuticals such as vaccines and stem cells, as well as increased research and development activities, the overall cell culture market is expected to grow at an impressive CAGR of 11.8% between 2023 and 2033, surpassing a valuation of around US$ 88.6 billion by 2033.

Cell culture is predicted to fuel market expansion in the pharmaceutical and biotechnology sectors, diagnostic laboratories, and research institutes for drug development and production, as well as diagnostic screening. The market is also predicted to be driven by the growing popularity of 3D cell grown techniques in fundamental research and drug delivery, as well as a desire for single-use technologies, an increase in chronic diseases, and increased demand for biopharmaceuticals. Furthermore, growing awareness of the multiple benefits of cell-based vaccines, together with rising need for monoclonal antibodies (mAbs), is driving greater demand for cell cultures.

Key Players:

  • Danaher Corporation
  • Thermo Fisher Scientific
  • Becton
  • Dickinson and Company
  • corning Incorporated
  • Merck KGaA
  • PromoCell GmbH
  • Sartorius AG, among others

Get More Details@ https://www.futuremarketinsights.com/reports/cell-culture-market

Key Segments

By Product:

  • Consumables
    • Sera
    • Media
    • Reagents
    • Vessels
    • Accessories
  • Equipment
    • Supporting Equipment
    • Bioreactors
    • Storage Equipment

By Application:

  • Biopharmaceutical Production
    • Monoclonal antibodies
    • Vaccines production
    • Other therapeutic proteins
  • Diagnostics
    • Drug Screening & Development
      • Tissue Engineering & Regenerative Medicine
    • Cell and gene therapy
  • Others

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Others

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more